Trevena Inc. buy melinda
Start price
21.11.17
/
50%
€42.17
Target price
19.12.17
€58.63
Performance (%)
-14.71%
End price
19.12.17
€35.97
Summary
This prediction ended on 19.12.17 with a price of €35.97. The prediction for Trevena Inc. disappointed with a performance of -14.71%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Trevena Inc. | - | - | - | - |
| iShares Core DAX® | -1.862% | -1.624% | 0.645% | 51.035% |
| iShares Nasdaq 100 | -3.322% | 3.321% | 32.004% | 86.512% |
| iShares Nikkei 225® | -2.299% | 3.437% | 51.012% | 58.809% |
| iShares S&P 500 | -1.313% | 2.435% | 23.006% | 65.411% |
Comments by melinda for this prediction
In the thread Trevena Inc. diskutieren
Trevena, Inc. ist ein biopharmazeutisches company.It entdeckt, entwickelt
(Vom Mitglied beendet)